Document:

Exhibit 10.3

 

NEITHER THIS NOTE NOR ANY SECURITIES THAT
MAY BE ISSUED UPON THE CONVERSION HEREOF HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”),
STATE SECURITIES LAWS, OR LAWS OF ANY FOREIGN JURISDICTION. NEITHER THIS NOTE NOR ANY SUCH SECURITIES MAY BE SOLD, ASSIGNED, OFFERED,
PLEDGED, OR OTHERWISE TRANSFERRED IN THE ABSENCE OF EITHER (I) AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND STATE SECURITIES
LAWS OR (II) THE COMPANY RECEIVING AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY STATING THAT SUCH SALE, ASSIGNMENT, OFFER,
PLEDGE, OR OTHER TRANSFER IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF THE ACT AND STATE SECURITIES
LAWS.

 

Nano Vibronix,
INC.

 

FORM OF CONVERTIBLE PROMISSORY NOTE

 

	$_____________	November __, 2011

 

Investor: ________________

 

FOR VALUE RECEIVED,
subject to the terms contained herein, the undersigned, Nano Vibronix, Inc., a Delaware corporation (the “Company”),
hereby promises to pay to the order of the investor set forth above (the “Investor”), the amount stated above (the
“Principal Amount”) plus interest thereon calculated from the date hereof until paid in full at the annual rate of
ten percent (10%), compounded annually. The Company shall pay the unpaid Principal Amount and interest accrued hereunder in lawful
money of the United States in full on demand on the earlier of an “Event of Default” (as defined below) or November
15, 2014 (the “Maturity Date”), unless it has been previously converted pursuant to Section Error! Reference
source not found. hereof, in which case all outstanding principal and accrued interest under this Note will be satisfied in
full by virtue of such conversion. This Convertible Promissory Note is one of the convertible promissory notes issued by the Company
in connection with its issuance and sale of $1,000,000 of convertible promissory notes pursuant to that certain Convertible Promissory
Note Subscription Agreement dated as of November ___, 2011 by and among the Company, the Investor and the other purchasers of Notes
(as such agreement may be amended, supplemented or otherwise modified from time to time, the “Subscription Agreement”).

 

		1.	Prepayment. This Note may not be prepaid without the prior written consent of the Investor.

 

		2.	Conversion.

 

		a.	Definitions.

 

		i.	“Issuance Conversion Event” shall mean an aggregate investment in the Company of $3,000,000
or more in one transaction or a series of related transactions occurring after the date hereof, in which the Company shall have
issued shares in the Company or securities (including convertible debt) exercisable or convertible into shares in the Company.

 

    	 

    	 

    

 

		ii.	“Entity Conversion Event” shall mean a sale,
lease, licensing, exchange or other transfer by the Company of all or substantially all of the Company’s business assets,
sale of all or substantially all of the shares in the Company, reorganization, or consolidation or merger of the Company into
or with any other entity except any such merger or consolidation involving the Company or a subsidiary in which (A) the
shares of the surviving or resulting corporation (or if the surviving or resulting corporation is a wholly owned subsidiary of
another corporation immediately following such merger or consolidation, the parent corporation of such surviving or resulting
corporation) are not listed or traded on any exchange and (B) the shares of capital stock of the Company outstanding immediately
prior to such merger or consolidation continue to represent, or are converted into or exchanged for shares of capital stock that
represent, immediately following such merger or consolidation, at least a majority, by voting power, of the capital stock of (1)
the surviving or resulting corporation or (2) if the surviving or resulting corporation is a wholly owned subsidiary of another
corporation immediately following such merger or consolidation, the parent corporation of such surviving or resulting corporation.

 

		iii.	“Conversion Price” shall mean $0.284 per
share of Series B-1 Participating Convertible Preferred Stock, par value $.001 per share, of the Company. Such amount shall be
appropriately adjusted in the case of a stock dividend, stock split or combination.

 

		b.	If an Issuance Conversion Event or Entity Conversion Event shall occur prior to the Maturity Date,
this Note (including accrued but unpaid interest) shall automatically be converted, at the Conversion Price, into shares of Series
B-1 Participating Convertible Preferred Stock of the Company, par value $.001 per share.

 

		c.	Election to Convert. At any time prior to the Maturity Date, the Investor may elect by written
notice to the Company and the surrender of this Note to convert this Note (including accrued but unpaid interest), at the Conversion
Price, into shares of Series B-1 Participating Convertible Preferred Stock of the Company, par value $.001 per share.

 

		d.	No Fractional Shares. The Company shall not issue any fractional shares on conversion of
this Note. If on any conversion of this Note a fraction of a share results, the Company shall pay the Investor the cash value of
that fractional share, calculated on the basis of the Conversion Price.

 

		e.	No Rights as Shareholder. This Note does not by itself entitle the Investor to any voting
rights or other rights as a shareholder of the Company.

 

    	2

    	 

    

 

		3.	Event of Default.

 

		a.	“Event of Default” means any of the following:

 

		i.	The failure of the Company to pay when due any amounts due hereunder that remain unpaid ten (10)
business days after the Company receives written notice thereof;

 

		ii.	The Company’s breach of a representation or obligation in the Subscription Agreement which
remains uncured for more than 30 days after the Company receives written notice thereof; or

 

		iii.	The Company shall have entered against it by a court having jurisdiction thereof a decree or order
for relief in respect to the Company in an involuntary case under any applicable bankruptcy, insolvency or other similar law, or
a receiver, liquidator, assignee, custodian, trustee, sequestrator or other similar official will have been appointed for the Company
or for any substantial part of the Company’s property, or the winding up or liquidation of the Company’s affairs will
have been ordered; or the Company will have commenced a voluntary case under any applicable bankruptcy, insolvency or other similar
law, or consent to the entry of an order for such relief in an involuntary case under any such law, or any such involuntary case
will have commenced, and not been dismissed within 90 days, or the Company will have consented to the appointment of or taking
possession by a receiver, liquidator, assignee, trustee, custodian, sequestrator or other similar official for the Company or for
any substantial part of the Company’s property, or make any general assignment for the benefit of creditors.

 

		b.	Upon the occurrence, and at any time during the continuance, of an Event of Default, the Investor,
by notice to the Company, may declare all unpaid principal and interest and all other amounts payable under the Notes to be immediately
due and payable and same shall become immediately due and payable upon such notice without presentment, demand, protest or further
notice of any kind; provided, however, that in the event of the occurrence of an Event of Default specified in subparagraph (iii)
above, this Note, all such interest and other amounts payable to Investor hereunder, shall automatically become due and payable,
without presentment, demand, protest or other notice of any kind.

 

		4.	Usury Savings Clause. The Company and the Investor intend to comply at all times with usury
laws. If at any time such laws would render usurious any amounts due under this Note, then it is the Company’s and the Investor’s
express intention that the Company not be required to pay interest on this Note at a rate in excess of the maximum lawful rate,
that the provisions of this section will control over all other provisions of this Note that appear to be in conflict hereunder,
that such excess amount will be immediately credited to the principal balance of this Note (or, if this Note has been fully paid,
refunded by the Investor to the Company), and the provisions hereof will be immediately reformed and the amounts thereafter decreased,
so as to comply with the then-applicable usury law, but so as to permit the recovery of the fullest amount otherwise due under
this Note.

 

    	3

    	 

    

 

		5.	General Provisions.

 

		a.	Amendments and Waivers. This Note and any term hereof may be amended, waived, discharged
or terminated only by an instrument in writing signed by the Company and the Investor or as otherwise provided in the Subscription
Agreement.

 

		b.	Notices. Any notice required or permitted hereunder shall be given in writing and shall
be deemed effectively given upon personal delivery and if a fax number has been provided, upon delivery (with answerback confirmed),
addressed to a party at its address and the fax number, if any, shown below or at such other address and fax number as such party
may designate by three days advance notice to the other party.

 

Any notice to the Investor shall
be sent to the address set forth on the signature page hereof.

 

	Any notice to the Company shall be sent to:	With a copy to: 	 
	 	 	 
	Nano Vibronix, Inc.	Nano Vibronix, Inc. 	 
	601 Chestnut Street 	Fax:   +972 4 820 2794     	 
	Cedarhurst, NY 11516	 	 
	Attention: Dr. Harold Jacob	 	 
	Fax: (516) 569 6872	 	 

 

		c.	Severability. If any provision of this Note is held to be invalid, illegal, or unenforceable,
the validity, legality and enforceability of the remaining provisions of this Note will not be affected or impaired.

 

		d.	Headings. The descriptive headings of the articles, sections, and subsections of this Note
are for convenience of reference only. They do not constitute a part of this Note and do not affect this Note’s construction
or interpretation.

 

		e.	Governing Law; Jurisdiction. The laws of the State of New York govern all matters arising
out of or relating to this Note, including, without limitation, its interpretation, construction, performance, and enforcement,
without giving effect to such State’s conflicts of law principles or rules of construction concerning the drafter hereof.
Each party hereby irrevocably consents and submits to the jurisdiction of any New York State or United States Federal Court sitting
in the State of New York, County of New York, over any action or proceeding arising out of or relating to this Note and irrevocably
consents to the service of any and all process in any such action or proceeding by registered mail addressed to such party at its
address shown below. Each party further waives any objection to venue in New York and any objection to an action or proceeding
in such state and county on the basis of forum non-conveniens. Each party also waives any right to trial by jury.

 

[Signature Page Follows]

 

    	4

    	 

    

 

The parties are signing
and delivering this Note as of the date stated in the caption of this Note.

 

	 	
        COMPANY: 
	 
	 	 	 
	 	NANO VIBRONIX, INC.	 
	 	 	 
	 	By:	 	 
	 	 	 
	 	
        INVESTOR:

         
	 
	Investor Address:	 	 
	 	 	 
	 	By:	 	 
	 	Name:	 	 
	 	Title:	 	 

 

[Acknowledgment and Receipt of Investor
to Convertible Promissory Note]Exhibit 10.4

 

NANO VIBRONIX, INC.

 

FORM OF SUBSCRIPTION AGREEMENT

CONVERTIBLE PROMISSORY NOTES

 

SUBSCRIPTION AGREEMENT
(the “Agreement”) dated as of November __, 2011, between Nano Vibronix, Inc., a Delaware corporation (the “Company”),
and the persons who execute this agreement as investors (collectively, the “Investors”).

 

WITNESSETH:

 

WHEREAS, the Company
desires to sell to the Investors, and the Investors desire to purchase, up to $1,000,000 in aggregate principal amount of convertible
promissory notes of the Company in substantially the form attached hereto as Exhibit 1 (the “Notes”).

 

NOW, THEREFORE, in
consideration of the mutual covenants contained herein, the parties hereto hereby agree as follows:

 

		1.	Purchase and Sale of Securities.

 

1.1.       Sale
and Issuance of Notes. The Company shall sell to the Investors and the Investors shall purchase from the Company, up to $1,000,000
in aggregate principal amount of Notes for an aggregate purchase price of US$1,000,000.

 

1.2.       The
closing (the “Closing”) of the purchase and sale of the Notes hereunder shall take place within three (3)
business days of the date of this Agreement or such other date agreed to by the Company and the Investors (the “Closing
Date”). The Closing shall take place remotely by means of and concurrently with the electronic or facsimile exchange
of documents and signatures at the Company or at such location as is mutually acceptable to the Investors and the Company. At the
Closing:

 

(a)       each Investor
shall deliver to the Company by wire transfer as set forth below:

Mellon Bank Pittsburdgh, PA

ABA # :            
           043000261

FFC:                
            Merrill Lynch

Account # :                  
101-1730

Name on the account:    NanoVibronix
Inc

FFC:                            
831-07B23

or such other
method of payment as the Company shall approve, an amount equal to the purchase price of the Note purchased by such Investor hereunder;
and

 

(b)      the Company
shall issue and deliver to each Investor a Note in the name of the Investor, in the principal amount equal to the purchase price
paid by such Investor; and

 

    	 

    	 

    

 

(c)      the Company
shall have obtained all requisite approvals and waivers of its Board of Directors and stockholders with respect to the transactions
described herein and the amendment and restatement of the Company’s certificate of incorporation in substantially the form
attached hereto as Exhibit 2 and shall have filed such certificate with the Secretary of State of the State of Delaware.

 

2.          Representations and Warranties
of the Company. The Company hereby makes the following representations and warranties only:

 

2.1         The Company
(i) is a corporation duly organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation,
(ii) has the corporate power and authority to own or lease its properties as and in the places where such business is conducted
and to carry on its business as conducted, and (iii) is duly qualified as a foreign corporation authorized to do business in every
jurisdiction where the failure to so qualify, individually or in the aggregate, would have a material adverse effect on the operations,
assets, liabilities, financial condition or business of the Company or its subsidiary (“Material Adverse Effect”).

 

2.2         The Company’s
subsidiary is duly incorporated and validly existing under the laws of its jurisdiction of incorporation and is qualified to do
business as a foreign corporation in each jurisdiction in which qualification is required, except where failure to so qualify would
not have a Material Adverse Effect.

 

2.3         As of the
date of this Agreement (assuming that the Restated Certificate has been filed) and as of the Closing, the Company (i) has the requisite
corporate power and authority to execute, deliver and perform this Agreement and the other documents set forth in Section 1.2 above
(“Transaction Documents”) and to incur the obligations herein and therein and (ii) has been authorized by all necessary
corporate action to execute, deliver and perform this Agreement and the other Transaction Documents and to consummate the transactions
contemplated hereby and thereby (the “Contemplated Transactions”).

 

2.4         Each of this
Agreement and the other Transaction Documents is a valid and binding obligation of the Company enforceable in accordance with its
terms except as limited by applicable bankruptcy, reorganization, insolvency, moratorium or similar laws affecting the enforcement
of creditors’ rights and the availability of equitable remedies (regardless of whether such enforceability is considered
in a proceeding at law or equity).

 

2.5          As of the date
of this Agreement (assuming that the Restated Certificate has been filed) and as of the Closing, the issuance of the Notes and
the shares of Series B-1 Convertible Preferred Stock, par value $.001 per share, of the Company (“Preferred B Shares”)
issuable upon a conversion of the Notes (the “Conversion Shares”) has been duly authorized by all necessary corporate
action on the part of the Company and, when issued to, delivered to the Investors in accordance with this Agreement and the Notes,
the Conversion Shares will be validly issued, fully paid and non-assessable.

 

2.6          The Company shall at all times reserve and keep
available sufficient Preferred B-1 Shares and common stock solely for issuance and delivery upon a conversion of the Notes.

 

    	2

    	 

    

 

3.           Representations and Warranties
and Agreement of the Investors. Each Investor represents and warrants to the Company as follows:

 

3.1.       Authorization. Each
Investor (i) has full power and authority to execute, deliver and perform this Agreement and the other Transaction Documents to
which it is a party and to incur the obligations herein and therein and (ii) if applicable, has been authorized by all necessary
corporate action to execute, deliver and perform this Agreement and the other Transaction Documents and to consummate the Contemplated
Transactions. Each of this Agreement and the other Transaction Documents is a valid and binding obligation of Investor enforceable
in accordance with its terms, except as limited by applicable bankruptcy, reorganization, insolvency, moratorium or similar laws
affecting the enforcement of creditors’ rights and the availability of equitable remedies (regardless of whether such enforceability
is considered in a proceeding at law or equity).

 

3.2.       Securities Laws Representations
and Covenants of Investors.

 

(a)        This Agreement
is made with each Investor in reliance upon such Investor’s representation to the Company, which by such Investor’s
execution of this Agreement such Investor hereby confirms, that the Notes and any Conversion Shares to be received by such Investor
will be acquired for investment for such Investor’s own account, not as a nominee or agent, and not with a view to the resale
or distribution of any part thereof such that such Investor would constitute an “underwriter” under the Securities
Act of 1933, as amended (the “Securities Act”). The Investor has not granted and shall not grant any right to
any other person to acquire the Notes or the Conversion Shares except as permitted by the Securities Act and other applicable securities
laws.

 

(b)        Each Investor
understands and acknowledges that the offering of the Notes pursuant to this Agreement will not be registered under the Securities
Act or qualified under any other applicable securities laws on the grounds that the offering and sale of the Securities are exempt
from registration and qualification and that the Company’s reliance upon such exemption is predicated upon such Investor’s
representations set forth in this Agreement.

 

(c)        Each Investor
covenants that, unless the Notes, the Conversion Shares or any other securities of the Company received in respect of the foregoing
have been registered pursuant to the Securities Act, such Investor will not dispose of such securities unless and until such Investor
shall have notified the Company of the proposed disposition and shall have furnished the Company with an opinion of counsel reasonably
satisfactory in form and substance to the Company and its counsel to the effect that (i) such disposition will not require
registration under the Securities Act and (ii) appropriate action necessary for compliance with the Securities Act and any
applicable state, local or foreign law has been taken. Therefore, such Investor may be required to hold such securities for an
indeterminate period.

 

    	3

    	 

    

 

(d)        Each Investor
further represents that such Investor (i) is able to fend for itself in the Contemplated Transactions; (ii) has such knowledge
and experience in financial and business matters as to be capable of evaluating the merits and risks of such Investor’s prospective
investment in the Notes; (iii)  has the ability to bear the economic risks of such Investor’s prospective investment
and can afford the complete loss of such investment; (iv)  has received all the information it considers necessary or appropriate
for deciding whether to purchase the Notes; (v)  has had access to officers of the Company and an opportunity to ask questions
of and receive satisfactory answers from such officers; (vi) qualifies as an “accredited investor” as such term is
defined under Rule 501 promulgated under the Securities Act; and (vi) in the case a corporation, a partnership, a trust or other
business entity, further represents by execution of this Agreement that it has not been organized for the purpose of purchasing
the Securities.

 

(e)        The maximum
liability of the Company under this Agreement to each Investor shall not exceed the purchase price paid plus accrued interest by
such Investor. An Investor may not bring any claim arising out of this Agreement unless written notice of the claim shall have
been given to the Company no later than 3 months following the date that the Company's financial statements for the period ending
31 December 2011 shall be made available. This provision shall not affect an Investor’s ability to enforce payment due under
the Notes.

 

(f)         Each Investor
shall provide all information and execute all documents that the Company shall deem necessary to prepare and file with the SEC
a Form D concerning the sale of the Securities.

 

3.3.        Legends. The Notes and
all certificates for the Conversion Shares, and each certificate representing any other securities of the Company received in respect
of the foregoing, and each certificate for any such securities issued to subsequent transferees of any such certificate shall bear
a legend substantially in the following form:

 

“NEITHER THIS
NOTE NOR ANY SECURITIES THAT MAY BE ISSUED UPON THE CONVERSION HEREOF HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE “ACT”), STATE SECURITIES LAWS, OR LAWS OF ANY FOREIGN JURISDICTION. NEITHER THIS NOTE NOR ANY SUCH SECURITIES
MAY BE SOLD, ASSIGNED, OFFERED, PLEDGED, OR OTHERWISE TRANSFERRED IN THE ABSENCE OF EITHER (I) AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE ACT AND STATE SECURITIES LAWS OR (II) THE COMPANY RECEIVING AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY STATING
THAT SUCH SALE, ASSIGNMENT, OFFER, PLEDGE, OR OTHER TRANSFER IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS
OF THE ACT AND STATE SECURITIES LAWS.”

 

In addition, such cer`ificates shall bear
any legend that, in the opinion of the Company’s counsel, is required under the other Transaction Documents or pursuant to
any state, local or foreign law governing the Notes, the Conversion Shares and any other securities of the Company received in
respect of the foregoing.

 

    	4

    	 

    

 

3.4.        Brokers
or Finders. Each Investor represents and warrants that neither the Company nor the Investor has incurred, directly
or indirectly, as a result of any action taken by the Investor, any liability for brokerage of finders’ fees or agents’
commissions or any similar charges in connection with this Agreement.

 

3.5.        Buyout Proposal. 
If at any time (i) the Company receives from any third party (in which no stockholder has a significant interest) a bona fide
offer or proposal (a “Buyout Proposal”) to purchase all of the shares of the Company, or all or substantially all of
the assets of the Company, or to effect a merger or consolidation with the Company, which is conditioned upon the sale of all shares
of the Company to such third party or stockholder approval and (ii) the holders of shares representing seventy five percent (75%)
of the aggregate voting power of the Company approve the Buyout Proposal, then the Investors shall transfer their stock in the
Company to such third party or shall vote in favor of the proposed Buyout Proposal, as applicable.

 

4.           Miscellaneous.

 

4.1.        Entire Agreement; Successors
and Assigns. This Agreement (including all schedules and exhibits thereto) constitutes the entire contract between the parties
relative to the subject matter hereof and thereof. Any previous agreement among the parties with respect to the sale of the Securities
is superseded by this Agreement. The terms and conditions of this Agreement shall inure to the benefit of and be binding upon the
respective executors, administrators, heirs, successors and assigns of the parties. Except as expressly provided herein, nothing
in this Agreement, expressed or implied, is intended to confer upon any party, other than the parties hereto, any rights, remedies,
obligations or liabilities under or by reason of this Agreement.

 

4.2.        Governing Law; Jurisdiction.
This Agreement shall be governed by and construed in accordance with the General Corporation Law of the State of Delaware as to
matters within the scope thereof, and as to all other matters shall be governed by and construed in accordance with the internal
laws of the State of New York without regard to principles of conflicts of law. Each party hereby irrevocably consents and submits
to the jurisdiction of any New York State or United States Federal Court sitting in the State of New York, County of New York,
over any action or proceeding arising out of or relating to this Agreement and irrevocably consents to the service of any and all
process in any such action or proceeding by registered mail addressed to such party at its address shown below. Each party further
waives any objection to venue in New York and any objection to an action or proceeding in such state and county on the basis of
forum non-conveniens. Each party also waives any right to trial by jury.

 

4.3.        Counterparts. This Agreement
may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute
one and the same instrument.

 

4.4.        Headings. The headings
of the sections of this Agreement are for convenience and shall not by themselves determine the interpretation of this Agreement.

 

    	5

    	 

    

 

4.5.        Notices. Any notice
required or permitted hereunder shall be given in writing and shall be deemed effectively given upon personal delivery and if a
fax number has been provided, upon delivery (with answerback confirmed), addressed to a party at its address and the fax number,
if any, shown below or at such other address and fax number as such party may designate by three days advance notice to the other
party.

 

Any notice to the Investors shall be sent
to the addresses set forth on the signature pages hereof.

	.Any notice to the Company shall be sent to:	 	With a copy to:
	 	 	 	 
	Nano Vibronix Inc.	 	 	 
	601 Chestnut Street	 	 	 
	Cedarhurst, NY 11516	 	 	Nano Vibronix, Inc.
	Attention: Dr. Harold Jacob	 	 	Fax:   +972 4 820 2794     
	Fax: 516 569 6872	 	 	 

 

4.6.        Severability. Whenever
possible, each provision of this Agreement shall be interpreted in such a manner as to be effective and valid under applicable
law, but if any provision of this Agreement shall be deemed prohibited or invalid under such applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, and such prohibition or invalidity shall not invalidate the remainder
of such provision or any other provision of this Agreement.

 

4.7.        Expenses. Irrespective
of whether the Closing is effected, the Company shall pay all costs and expenses that it incurs with respect to the negotiation,
execution, delivery and performance of this Agreement. Each Investor shall be responsible for all costs incurred by it in connection
with the negotiation, execution, delivery and performance of this Agreement including, but not limited to, legal fees and expenses.

 

4.8        Amendments and Waivers.
Any provision of this Agreement may be amended and the observance of any provision of this Agreement may be waived (either generally
or in a particular instance and either retroactively or prospectively), only with the written consent of the Company and the holders
of a majority of the aggregate then-outstanding principal amount of the Notes. Any amendment or waiver effected in accordance with
this Section shall be binding upon each holder of any Notes purchased under this Agreement at the time outstanding, and the Company.

 

[REMAINDER OF PAGE INTENTIONALLY BLANK]

 

    	6

    	 

    

 

SIGNATURE PAGE

TO

NANO VIBRONIX INC.

SUBSCRIPTION AGREEMENT

 

IF the PURCHASER is an INDIVIDUAL, please
complete the following:

 

IN WITNESS WHEREOF, the undersigned has
executed this Agreement this __ day of ______________.

 

Amount of Subscription:

$_________ 

	 	 
	 	Investor Name:
	 	 
	 	 
	 	Signature of Investor
	 	 
	 	 
	 	Social Security Number
	 	 
	 	 
	 	Address and Fax Number
	 	 
	 	 

 

ACCEPTED AND AGREED:

 

NANO VIBRONIX INC.

 

	By:	 	 
	 	Name:	 
	 	Title:	 

 

	Dated:	 	 

 

 

    	 

    	 

    

 

SIGNATURE PAGE

TO

NANO VIBRONIX, INC.

SUBSCRIPTION AGREEMENT

 

IF the INTERESTS will be held as JOINT TENANTS,
as TENANTS IN COMMON, or as COMMUNITY PROPERTY, please complete the following:

 

IN WITNESS WHEREOF, the undersigned has
executed this Agreement this __ day of ____________.

 

	Amount of Subscription:	 
	$ ____________	Print Name of a Purchaser
	 	 
	 	 
	 	Signature of a Purchaser
	 	 
	 	 
	 	Print Name of Spouse or Other Purchaser
	 	 
	 	 
	 	Signature of Spouse or Other Purchaser
	 	 
	 	 
	 	Social Security Number
	 	 
	 	 
	 	Address
	 	 
	 	 

 

ACCEPTED AND AGREED:

 

NANO VIBRONIX INC.

 

	By:	 	 
	 	Name:	 
	 	Title:	 

 

	Dated:	 	 

 

    	 

    	 

    

 

SIGNATURE PAGE

TO

NANO VIBRONIX INC.

SUBSCRIPTION AGREEMENT

 

IF the PURCHASER is a PARTNERSHIP, CORPORATION,
TRUST or OTHER ENTITY, please complete the following:

 

IN WITNESS WHEREOF, the undersigned has
executed this Agreement this __ day of ______________.

 

	Amount of Subscription:	 	 
	$ _____________	 	 
	 	 	 
	 	Print Full Legal Name of Partnership,	 
	 	Company, Trust or Other Entity	 
	 	 	 
	 	 	 
	 	By:	 	 
	 	(Authorized Signatory)	 
	 	Name:	 	 
	 	Title:	 	 

 

	 	Address and Fax Number:	 	 

 

	 	 	 
	 	 	 
	 	Employer Identification Number:	 	 

 

	 	Date and State of Incorporation or Organization:	 	 

	 	Date on which Taxable Year Ends:	 	 

 

ACCEPTED AND AGREED:

 

NANO VIBRONIX INC.

 

	By:	 	 

Name:

Title:

Dated:

 

    	-2-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00226-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00226-of-00352.parquet"}]]